High Court Won't Review $58M Award In Wyeth Drug Suit

Law360, New York (June 20, 2011, 12:21 PM EDT) -- The U.S. Supreme Court on Monday denied Wyeth Pharmaceuticals Inc.’s appeal of a judgment awarding nearly $58 million to three women who alleged the company’s hormone replacement drugs caused them to develop breast cancer.

Without comment, the high court shot down Wyeth’s petition to overturn the Nevada Supreme Court’s award of $22.8 million in compensatory damages and $35 million in punitive damages to Arlene Rowatt, Pamela Forrester and Jeraldine Scofield, who suffered from breast cancer after taking Premarin and Prempro.

The women filed separate suits in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.